.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Cerilliant
Argus Health
Boehringer Ingelheim
US Department of Justice
Novartis
UBS
Chubb
Moodys
McKesson

Generated: December 18, 2017

DrugPatentWatch Database Preview

LEVONORDEFRIN; MEPIVACAINE HYDROCHLORIDE - Generic Drug Details

« Back to Dashboard

What are the generic sources for levonordefrin; mepivacaine hydrochloride and what is the scope of levonordefrin; mepivacaine hydrochloride freedom to operate?

Levonordefrin; mepivacaine hydrochloride
is the generic ingredient in six branded drugs marketed by Solvay, Eastman Kodak, Septodont Inc, Belmora Llc, Dentsply Pharm, and Deproco, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for levonordefrin; mepivacaine hydrochloride. Six suppliers are listed for this compound.

Summary for LEVONORDEFRIN; MEPIVACAINE HYDROCHLORIDE

Pharmacology for LEVONORDEFRIN; MEPIVACAINE HYDROCHLORIDE

Ingredient-typeAmides
Drug ClassAmide Local Anesthetic
Physiological EffectLocal Anesthesia
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Septodont IncISOCAINE HYDROCHLORIDE W/ LEVONORDEFRINlevonordefrin; mepivacaine hydrochlorideINJECTABLE;INJECTION084697-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Belmora LlcMEPIVACAINE HYDROCHLORIDE W/ LEVONORDEFRINlevonordefrin; mepivacaine hydrochlorideINJECTABLE;INJECTION084850-002Oct 21, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
DeprocoSCANDONEST Llevonordefrin; mepivacaine hydrochlorideINJECTABLE;INJECTION088388-001Oct 10, 1984RXNoYes► Subscribe► Subscribe► Subscribe
Eastman KodakCARBOCAINE W/ NEO-COBEFRINlevonordefrin; mepivacaine hydrochlorideINJECTABLE;INJECTION012125-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Dentsply PharmPOLOCAINE W/ LEVONORDEFRINlevonordefrin; mepivacaine hydrochlorideINJECTABLE;INJECTION089517-001Apr 14, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
SolvayARESTOCAINE HYDROCHLORIDE W/ LEVONORDEFRINlevonordefrin; mepivacaine hydrochlorideINJECTABLE;INJECTION085010-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Fish and Richardson
Chubb
Cerilliant
AstraZeneca
Covington
Medtronic
Julphar
Queensland Health
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot